Evidence map›Paper›PMID 21420234›Full record

ArticleCancer letters2011

Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.

G L van Sluis, L W Brüggemann, C T Esmon, P W Kamphuisen, D J Richel, H R Büller, C J F van Noorden, C A Spek

Abstract read
In one paragraph

Article in Cancer letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

G L van SluisDepartment of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
L W Brüggemann
C T Esmon
P W Kamphuisen
D J Richel
H R Büller
C J F van Noorden
C A Spek
Academic Medical Center · NL

Funding

MOLECULAR INTERACTIONS IN INFLAMMATION AND COAGULATIONP01HL054804 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CUMMINGS, RICHARD D · 1995 to 1999
–
NHLBI NIH HHS P01 HL054804
6 · The paper itself

Abstract

Fibrinogen and platelets play an important role in cancer cell survival in the circulation by protecting cancer cells from the immune system. Moreover, endogenous activated protein C (APC) limits cancer cell extravasation due to sphingosine-1-phosphate receptor-1 (S(1)P(1)) and VE-cadherin-dependent vascular barrier enhancement. We aimed to study the relative contribution of these two mechanisms in secondary tumor formation in vivo. We show that fibrinogen depletion limits pulmonary tumor foci formation in an experimental metastasis model in C57Bl/6 mice but not in NOD-SCID mice lacking a functional immune system. Moreover, we show that in the absence of endogenous APC, fibrinogen depletion does not prevent cancer cell dissemination and secondary tumor formation in immune-competent mice. Overall, we thus show that endogenous APC is essential for immune-mediated cancer cell elimination.

Indexed as

AnimalsAntigens, CDBlood CoagulationBlood PlateletsCadherin 5CadherinsFibrinogenImmune SystemLung NeoplasmsMelanomaMelanoma, ExperimentalMiceMice, Inbred C57BLMice, SCIDNeoplasm MetastasisProtein CAntigens, CDCadherin 5CadherinsFibrinogenProtein CReceptors, LysosphingolipidThrombin

Identifiers

PMID21420234
PMCPMC3159049
OpenAlexW2166115939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.